NICOLINI, LAURA AMBRA
 Distribuzione geografica
Continente #
EU - Europa 6.758
AS - Asia 857
NA - Nord America 672
Continente sconosciuto - Info sul continente non disponibili 178
SA - Sud America 74
AF - Africa 17
OC - Oceania 1
Totale 8.557
Nazione #
IT - Italia 6.620
US - Stati Uniti d'America 624
SG - Singapore 326
CN - Cina 196
VN - Vietnam 152
BD - Bangladesh 100
FR - Francia 55
BR - Brasile 44
HK - Hong Kong 27
CA - Canada 22
DE - Germania 17
FI - Finlandia 16
IQ - Iraq 10
GB - Regno Unito 9
JP - Giappone 9
AR - Argentina 7
MX - Messico 7
ID - Indonesia 6
IN - India 6
NL - Olanda 6
UA - Ucraina 6
EC - Ecuador 5
ES - Italia 5
PH - Filippine 5
PY - Paraguay 5
RU - Federazione Russa 5
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
JM - Giamaica 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
KE - Kenya 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
PE - Perù 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
KY - Cayman, isole 1
LC - Santa Lucia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PL - Polonia 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
Totale 8.380
Città #
Genova 3.356
Genoa 1.928
Rapallo 621
Vado Ligure 577
Singapore 163
San Jose 142
Ashburn 50
Beijing 47
Lauterbourg 46
Ho Chi Minh City 45
Hanoi 37
New York 28
Bordighera 27
Hong Kong 26
Los Angeles 22
Helsinki 16
Milan 15
Council Bluffs 13
Frankfurt am Main 12
Santa Clara 12
Buffalo 10
Tianjin 8
Tokyo 8
Atlanta 7
Chicago 7
Rome 7
Montreal 6
Naples 6
Orem 6
Houston 5
Las Vegas 5
Mexico City 5
Philadelphia 5
Washington 5
Brooklyn 4
Dallas 4
Jacksonville 4
Kyiv 4
London 4
Marseille 4
Phoenix 4
Rio de Janeiro 4
Trenton 4
Turin 4
Baghdad 3
Biên Hòa 3
Bắc Giang 3
Cardiff 3
Charlotte 3
Da Nang 3
Detroit 3
Guarulhos 3
Ha Long 3
Knoxville 3
Miami 3
Minneapolis 3
Quảng Ngãi 3
Richmond 3
San Francisco 3
Santiago 3
Seregno 3
São Paulo 3
Thái Bình 3
Toronto 3
Tunis 3
Zurich 3
Acalanes Ridge 2
Amsterdam 2
Basra 2
Belleview 2
Boardman 2
Bossier City 2
Brandon 2
Bresso 2
Cape Town 2
Cedar Rapids 2
Chula Vista 2
Ciudad del Este 2
Dearborn 2
Des Moines 2
Dhaka 2
Eastman 2
Florence 2
Fort Wayne 2
Grand Rapids 2
Green Bay 2
Grove 2
Guayaquil 2
Haiphong 2
Huntsville 2
Hyderabad 2
Hải Dương 2
Kansas City 2
Kingston 2
Lewis Center 2
Lewistown 2
Louisville 2
Madrid 2
Memphis 2
Modena 2
Totale 7.447
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 345
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 229
Evaluation of insulin resistance in a cohort of HIV-infected youth. 211
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 210
Implementing TB control in a rural, resource-limited setting: The stop-TB Italia project in Senegal 206
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 202
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 196
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 196
Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe 193
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 191
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 181
Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course 180
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 177
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 177
Drug treatment for multidrug-resistant Acinetobacter baumannii infections 176
Weight gain: A possible side effect of all antiretrovirals 166
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 165
A global view to HBV chronic infection: Evolving strategies for diagnosis, treatment and prevention in immunocompetent individuals 163
Current status of newer carbapenems 162
Liver Enzyme Elevation During Darunavir-Based Antiretroviral Treatment in HIV-1-Infected Patients With or Without Hepatitis C Coinfection: Data from the ICONA Foundation Cohort. 162
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 162
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 159
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 158
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 157
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 154
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 153
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 152
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature 150
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 150
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 146
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 143
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 142
Tigecycline use in serious nosocomial infections: a drug use evaluation. 140
Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults. 137
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 136
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 136
Management of chronic viral hepatitis in the hematological patient 131
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 124
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 120
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 120
Incidence of candidaemia and relationship with flucanazole use in an intensive care unit 119
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 117
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency 114
The efficacy of the new anti HCV therapy, implementation of a path based on the logic of micro-elimination in the Department of Mental Health and Addictions ASL4 Chiavarese 105
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 104
Fulminant Hepatitis Associated with Echovirus 25 during Treatment with Ocrelizumab for Multiple Sclerosis 104
Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermis endocarditis and spondylodiscitis 99
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 96
Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus. 93
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 92
Comments on “Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C” 91
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 89
Insights on common vaccinations in HIV-infection: efficacy and safety 80
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients – Study of infectious diseases working party of EBMT 74
Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women? 74
Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection 69
HCV treatment in children and young adults with HIV/HCV co-infection in Europe 66
null 31
Totale 8.557
Categoria #
all - tutte 28.767
article - articoli 28.002
book - libri 0
conference - conferenze 765
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022629 28 19 34 78 25 62 23 140 54 72 24 70
2022/2023743 68 65 6 77 97 106 9 50 112 57 88 8
2023/2024430 12 51 5 50 36 92 36 34 25 8 38 43
2024/20251.378 30 91 27 122 190 150 143 229 60 56 119 161
2025/20262.257 261 56 205 131 294 163 297 93 171 222 152 212
2026/2027234 234 0 0 0 0 0 0 0 0 0 0 0
Totale 8.557